首页 > 市场调查报告书 > 食物/饮料

机能性食品

市场调查报告书

商品编码

1575779

全球营养保健品市场 - 2024-2031

Global Nutraceuticals Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 224 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年，全球营养保健品市场规模达4,431亿美元，预估至2031年将达6,842亿美元，2024-2031年预测期间复合年增长率为5.58%。

消费者对健康生活方式益处的认识不断提高，导致对保健补充剂的需求增加，特别是在註重健康的老龄化人群中。与生活方式相关的慢性病发病率的上升也强调了透过饮食选择进行预防性护理的必要性。此外，电子商务的发展使消费者更容易获得营养保健品，从而方便了他们的购买。

随着基于个人遗传和生活方式因素的个人化营养、对永续性的高度关注以及产品开发的持续创新等趋势，市场有望进一步扩大。例如，2024 年 7 月，Renewtra 作为印度营养保健品行业的新品牌推出，旨在透过其经过临床验证的透明标籤产品彻底改变市场。

美国糖尿病和肥胖症的高发生率推动了北美在全球营养保健品市场的主导地位。大约有 3730 万美国人患有糖尿病，超过 41.9% 的成年人属于肥胖人群，因此对补充剂和功能性食品的需求不断增长。随着注重健康的消费者寻求有效的解决方案，北美仍然是营养保健品产业的领导者。

市场动态

慢性病的增加

肥胖、糖尿病和心血管疾病 (CVD) 的惊人成长正在极大地推动全球营养保健品市场的发展。超过 10 亿人受到肥胖影响，5.37 亿成年人患有糖尿病，有效管理解决方案的紧迫性从未如此明显。消费者越来越多地寻求源自食物的营养保健品，这些产品对健康有益，有助于预防或控制这些慢性病。

预防性健康措施的转变反映了人们对饮食与疾病之间关键联繫的认识不断增强，促使人们探索增强福祉的自然选择。此外，由于对慢性病盛行率的担忧，消费者健康意识不断增强，正在推动营养保健品市场向前发展。

创新的监管批准和增强的配方

全球营养保健品市场由创新的监管审批和改进的配方推动。 2022 年11 月，Geno 推出了Avela 天然(R)-1,3-丁二醇，它提供了一种无糖成分，可以提高β-羟基丁酸水平，增强思维清晰度和运动表现，而无需限制饮食。 Avela 透过永续发酵从植物糖中提取，符合消费者对天然产品日益增长的需求。

此外，监管部门的批准，例如欧盟委员会于 2023 年 10 月对卡波姆聚合物的认可，使得能够创造出创新的、更易于吞嚥的配方。这些进步共同满足了不同消费者的需求和偏好，推动了功能性食品的发展，并为营养保健品市场的持续成长奠定了基础。

多样化的监管框架

由于监管框架多样化，全球营养保健品市场面临重大限制。每个国家都有自己的分类标准，考虑到一个地区对另一个地区的不同产品认知。这种不一致使合规性变得复杂，迫使公司分配时间和资源来应对各种法规。此外，某些领域严格的行销准则限制了可以做出的健康声明，从而阻碍了公司吸引消费者的能力。

细分市场分析

全球营养保健品市场根据类型、产品、来源、配销通路、应用和地区进行细分。

杂交种子的卓越性能和产量潜力

从来源来看，植物性细分市场在全球营养保健品市场中占据主导地位。这主要是由于消费者对天然和有机产品的需求不断增加，以及人们对植物源成分的健康益处的认识不断增强。此外，素食和纯素食饮食的趋势也促进了植物性营养保健品的流行。

纯素食者人数不断增加，预计到 2022 年将达到 8,800 万左右，这对植物性营养保健品的受欢迎程度产生了重大影响。随着越来越多的人采用素食和纯素饮食，对不含动物成分的产品的需求不断增长。这一趋势正在推动植物性产业的创新和扩张，推动细分市场的成长。

市场地域占有率

北美人口健康意识不断增强

北美主导全球营养保健品市场。消费者对健康的高层次意识有力地支持了北美在全球市场的领导地位。 2023 年 CRN 膳食补充剂消费者调查显示，74% 的美国成年人服用膳食补充剂，其中 55% 属于经常使用者。这项重大采用增强了补充剂在美国人日常健康中的重要作用。

广泛的使用反映了对预防性健康措施的坚定承诺，以及对营养保健品益处的日益认识，在有效的教育倡议、多样化的健康产品和支持性监管环境的支持下，推动了市场主导地位。随着对膳食补充剂的依赖不断增加，它与更广泛的整体健康运动一致，进一步巩固了它们在日常生活中的重要地位。

市场竞争格局

该市场的主要全球参与者包括达能公司、哥兰比亚公司、雀巢公司、拜耳公司、雅培营养品、GNC Holdings, LLC、Garden of Life、NOW Foods、Kellanova 和 Parry Nutraceuticals Limited。

俄罗斯-乌克兰战争影响

俄罗斯-乌克兰战争扰乱了供应链并导致原材料价格波动，从而影响了全球营养保健品市场。主要农产品的短缺增加了成本并影响了供应。此外，地缘政治紧张局势导致企业重新考虑采购策略，而消费者对健康和保健的兴趣日益浓厚，推动了对营养保健品的需求。

按类型

草药

蛋白质和胜肽

维生素和矿物质

益生元和益生菌

其他（脂肪酸和纤维）

按产品分类

功能性食品

谷物

麵包店和糖果店

乳製品

小吃

其他

功能性饮料

能量饮料

乳製品和乳製品替代饮料

果汁和蔬菜汁及饮料

非碳酸饮料

其他

膳食补充剂

平板电脑

液体

粉末

其他的

个人护理

按来源

植物性

以动物为基础

微生物

按配销通路

超市/大卖场

便利商店

专卖店

药局/药房

网路零售店

其他

按申请

健康与保健

运动营养

临床营养

按地区

北美洲

我们

加拿大

墨西哥

欧洲

德国

英国

法国

义大利

西班牙

欧洲其他地区

南美洲

巴西

阿根廷

南美洲其他地区

亚太

中国

印度

日本

澳洲

亚太其他地区

中东和非洲

主要进展

2024 年 9 月，Flore 推出了针对神经多样性的益生菌系列，包括通路支持和情绪支持，专为自闭症谱系障碍 (ASD) 患者配製。这些产品是与亚利桑那州立大学合作开发的，基于一项临床研究，该研究表明自闭症谱系障碍参与者经过三个月的治疗后，胃肠道不适和认知能力得到显着改善。

2024 年 6 月，Steadfast Nutrition 推出了三款新补充品：乳清蛋白、LIV Raw 和素食复合维生素大包装（180 片）。这些产品满足注重健康的个人和运动员的蛋白质和营养需求。这场发表会是在亚洲最大的健康健身盛会－国际健康运动健身节（IHFF）上举行的。

2024 年 6 月，RSSL 推出了新的膳食补充剂测试服务，为客户的研发、製造和供应链职能提供支援。该服务可确保可靠的周转和高品质结果，提供营养测试、新成分评估和监管支援等分析，以有效满足客户的需求。

为什么购买报告？

根据类型、产品、来源、配销通路、应用和区域可视化全球营养保健品市场细分，并了解关键商业资产和参与者。

透过分析趋势和共同开发来识别商业机会。

Excel 电子表格包含营养保健品市场的综合资料集，涵盖各个细分市场。

PDF 报告由详尽的质性访谈和深入研究后的综合分析组成。

产品映射以 Excel 形式提供，包含所有主要参与者的关键产品。

全球营养保健品市场报告将提供约 78 个表格、79 个图表和 224 页。

2024 年目标受众

製造商/买家

产业投资者/投资银行家

研究专业人员

新兴公司

Increasing consumer awareness about the benefits of a healthy lifestyle has led to greater demand for health supplements, particularly among aging populations who prioritize wellness. The rising incidence of lifestyle-related chronic diseases has also emphasized the need for preventive care through dietary choices. Additionally, the growth of e-commerce has made nutraceuticals more accessible to consumers, facilitating their purchase.

The market is poised for further expansion, with trends such as personalized nutrition based on individual genetic and lifestyle factors, a heightened focus on sustainability and ongoing innovation in product development. For instance, in July 2024, Renewtra has launched as a new brand in India's nutraceutical industry, aiming to revolutionize the market with its clinically proven, transparent-label products.

High rates of diabetes and obesity in US drive North America's dominance in the global nutraceuticals market. With approximately 37.3 million Americans having diabetes and over 41.9% of adults classified as obese, there is a growing demand for supplements and functional foods. As health-conscious consumers seek effective solutions, North America remains a leader in the nutraceutical industry.

Market Dynamics

Rise of Chronic Diseases

The frightening rise in obesity, diabetes and cardiovascular diseases (CVDs) is significantly driving the global nutraceutical market. With over 1 billion people affected by obesity and 537 million adults living with diabetes, the urgency for effective management solutions has never been clearer. Consumers are increasingly seeking nutraceutical products derived from food sources with health benefits that can help prevent or manage these chronic conditions.

The shift towards preventive health measures reflects a growing awareness of the critical link between diet and disease, prompting individuals to explore natural options that enhance well-being. Moreover, the rising health consciousness among consumers, fueled by concerns over chronic disease prevalence, is propelling the nutraceutical market forward.

Innovative Regulatory Approvals And Enhanced Formulations

The global nutraceutical market is driven by innovative regulatory approvals and enhanced formulations. In November 2022, Geno's launch of Avela natural (R)-1,3-Butanediol provides a sugar-free ingredient that elevates beta-hydroxybutyrate levels, enhancing mental clarity and athletic performance without requiring restrictive diets. Derived from plant sugars through sustainable fermentation, Avela aligns with the increasing consumer demand for natural products.

Additionally, regulatory approvals, such as the European Commission's endorsement of Carbopol Polymers, in October 2023, enable the creation of innovative, easier-to-swallow formulations. Together, these advancements cater to diverse consumer needs and preferences, driving the evolution of functional foods and positioning the nutraceutical market for sustained growth.

Diverse Regulatory Frameworks

The global nutraceuticals market faces significant restraints due to diverse regulatory frameworks. Each country has its classification criteria, considering different product perceptions from one region to another. This inconsistency complicates compliance, forcing companies to allocate time and resources to navigate various regulations. Additionally, strict marketing guidelines in some areas limit the health claims that can be made, hindering companies' ability to attract consumers.

Market Segment Analysis

The global nutraceuticals market is segmented based on type, product, source, distribution channel, application and region.

Superior Performance and Yield Potential of Hybrid Seeds

The plant-based segment dominates the global nutraceuticals market based on source. This is primarily due to the increasing consumer demand for natural and organic products, as well as growing awareness of the health benefits associated with plant-derived ingredients. Additionally, trends toward vegetarian and vegan diets contribute to the popularity of plant-based nutraceuticals.

The increasing number of vegans, estimated at around 88 million in 2022, significantly impacts the popularity of plant-based nutraceuticals. As more people adopt vegetarian and vegan diets, there's a growing demand for products that meet their nutritional needs without animal-derived ingredients. This trend is driving innovation and expansion in the plant-based sector, driving segment growth.

Market Geographical Share

Rising Health Consciousness Among North American Population

North America dominates the global nutraceuticals market. A high level of consumer awareness regarding wellness strongly supports North America's leadership in the worldwide market. The 2023 CRN Consumer Survey on Dietary Supplements reveals that 74% of US adults take dietary supplements, with 55% classified as regular users. This significant adoption enhances the vital role that supplements play in the daily health routines of Americans.

The widespread usage reflects a robust commitment to preventive health measures and a growing recognition of the benefits of nutraceuticals, driver market dominance, bolstered by effective education initiatives, a diverse range of product offerings health and a supportive regulatory environment. As reliance on dietary supplements continues to rise, it aligns with the broader movement towards holistic health, further solidifying their essential place in everyday life.

Market Competitive Landscape

The major global players in the market include Danone S.A., Glanbia plc, Nestle S.A., Bayer AG, Abbott Nutrition, GNC Holdings, LLC, Garden of Life, NOW Foods, Kellanova and Parry Nutraceuticals Limited.

Russia-Ukraine War Impact

The Russia-Ukraine war has impacted the global nutraceuticals market by disrupting supply chains and causing fluctuations in raw material prices. Shortages of key agricultural products have increased costs and affected availability. Additionally, geopolitical tensions have led companies to rethink sourcing strategies, while rising consumer interest in health and wellness has driven demand for nutraceuticals.

By Type

Herbals

Proteins & Peptides

Vitamins & Minerals

Prebiotics and Probiotics

Others (Fatty Acids and Fiber)

By Product

Functional Food

Cereal

Bakery and Confectionary

Dairy

Snack

Other

Functional Beverages

Energy Drinks

Dairy & Dairy Alternative Drinks

Fruit & Vegetable Juices and Drinks

Noncarbonated Drinks

Other

Dietary Supplements

Tablets

Liquid

Powder

Others

Personal Care

By Source

Plant-Based

Animal-Based

Microbial

By Distribution Channel

Supermarkets/Hypermarkets

Convenience Stores

Specialty Stores

Drug Stores/Pharmacies

Online Retail Stores

Other

By Application

Health and Wellness

Sports Nutrition

Clinical Nutrition

By Region

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In September 2024, Flore launched a probiotic line for neurodiversity, including pathways support and mood support, formulated for individuals with autism spectrum disorder (ASD). Developed in collaboration with Arizona State University, these products were based on a clinical study that showed significant improvements in gastrointestinal discomfort and cognitive abilities among ASD participants after three months of treatment.

In June 2024, Steadfast Nutrition launched three new supplements: Whey Protein, LIV Raw and a vegetarian Multivitamin mega pack with 180 tablets. These products cater to the protein and nutrient needs of health-conscious individuals and athletes. The launch took place at the International Health Sports and Fitness Festival (IHFF), Asia's largest health and fitness event.

In June 2024, RSSL introduced a new dietary supplement testing service to support clients in R&D, manufacturing and supply chain functions. This service ensures reliable turnaround and quality results, offering analyses such as nutrition testing, novel ingredient evaluation and regulatory support to meet clients' needs efficiently.

Why Purchase the Report?

To visualize the global nutraceuticals market segmentation based on type, product, source, distribution channel, application and region, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel spreadsheet containing a comprehensive dataset of the Nutraceuticals market, covering all levels of segmentation.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global nutraceuticals market report would provide approximately 78 tables, 79 figures and 224 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Product
3.3. Snippet by Source
3.4. Snippet by Distribution Channel
3.5. Snippet by Application
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise of Chronic Diseases
  - 4.1.1.2. Innovative Regulatory Approvals and Enhanced Formulations
- 4.1.2. Restraints
  - 4.1.2.1. Diverse Regulatory Frameworks
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Herbals
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Proteins & Peptides
6.4. Vitamins & Minerals
6.5. Prebiotics and Probiotics
6.6. Others (Fatty Acids and Fiber)

7. By Product

7.1. Introduction
7.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.3. Market Attractiveness Index, By Product
7.4. Functional Food
- 7.4.1. Introduction
- 7.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.4.3. Cereal
- 7.4.4. Bakery and Confectionary
- 7.4.5. Dairy
- 7.4.6. Snack
- 7.4.7. Other
7.5. Functional Beverages
- 7.5.1. Energy Drinks
- 7.5.2. Dairy & Dairy Alternative Drinks
- 7.5.3. Fruit & Vegetable Juices and Drinks
- 7.5.4. Noncarbonated Drinks
- 7.5.5. Other
7.6. Dietary Supplements
- 7.6.1. Tablets
- 7.6.2. Liquid
- 7.6.3. Powder
- 7.6.4. Others
7.7. Personal Care

8. By Source

8.1. Introduction
8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
8.3. Market Attractiveness Index, By Source
8.4. Plant-Based
- 8.4.1. Introduction
- 8.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.5. Animal-Based
8.6. Microbial

9. By Distribution Channel

9.1. Introduction
9.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3. Market Attractiveness Index, By Distribution Channel
9.4. Supermarkets/Hypermarkets
- 9.4.1. Introduction
- 9.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.5. Convenience Stores
9.6. Specialty Stores
9.7. Drug Stores/Pharmacies
9.8. Online Retail Stores
9.9. Other

10. By Application

10.1. Introduction
10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3. Market Attractiveness Index, By Application
10.4. Health and Wellness
- 10.4.1. Introduction
- 10.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.5. Sports Nutrition
10.6. Clinical Nutrition

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.8.1. US
  - 11.2.8.2. Canada
  - 11.2.8.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.8.1. Germany
  - 11.3.8.2. UK
  - 11.3.8.3. France
  - 11.3.8.4. Italy
  - 11.3.8.5. Spain
  - 11.3.8.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.8.1. Brazil
  - 11.4.8.2. Argentina
  - 11.4.8.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.8.1. China
  - 11.5.8.2. India
  - 11.5.8.3. Japan
  - 11.5.8.4. Australia
  - 11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Danone S.A.
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Glanbia plc
13.3. Nestle S.A.
13.4. Bayer AG
13.5. Abbott Nutrition
13.6. GNC Holdings, LLC
13.7. Garden of Life
13.8. NOW Foods
13.9. Kellanova
13.10. Parry Nutraceuticals Limited (*LIST NOT EXHAUSTIVE)